J Biol Chem, Vol. 275, Issue 10, 7071-7079, March 10, 2000
Ionomycin, a Carboxylic Acid Ionophore, Transports
Pb2+ with High Selectivity*
Warren L.
Erdahl
,
Clifford J.
Chapman
,
Richard W.
Taylor§, and
Douglas R.
Pfeiffer
¶
From the
Department of Medical Biochemistry, Ohio
State University, Columbus, Ohio 43210 and the § Department
of Chemistry and Biochemistry, University of Oklahoma,
Norman, Oklahoma 73019
 |
ABSTRACT |
Studies utilizing phospholipid vesicle loaded
with chelator/indicators for polyvalent cations show that ionomycin
transports divalent cations with the selectivity sequence
Pb2+ > Cd2+ > Zn2+ > Mn2+ > Ca2+ > Cu2+ > Co2+ > Ni2+ > Sr2+. The
selectivity of this ionophore for Pb2+ is in contrast to
that observed for A23178 and 4-BrA23187, which transport
Pb2+ at efficiencies that are intermediate between those of
other cations. When the selectivity difference of ionomycin for
Pb2+ versus Ca2+ was calculated
from relative rates of transport, with either cation present
individually and all other conditions held constant, a value of ~450
was obtained. This rose to ~3200 when both cations were present and
transported simultaneously. 1 µM Pb2+
inhibited the transport of 1 mM Ca2+ by
~50%, whereas the rate of Pb2+ transport approached a
maximum at a concentration of 10 µM Pb2+ when
1 mM Ca2+ was also present. Plots of log rate
versus log ionomycin or log Pb2+ concentration
indicated that the transporting species is of 1:1 stoichiometry,
ionophore to Pb2+, but that complexes containing an
additional Pb2+ may occur. The species transporting
Pb2+ may include H·IPb·OH, wherein ionomycin is ionized
once and the presence of OH
maintains charge neutrality.
Ionomycin retained a high efficiency for Pb2+ transport in
A20 B lymphoma cells loaded with Indo-1. Both Pb2+ entry
and efflux were observed. Ionomycin should be considered primarily as
an ionophore for Pb2+, rather than Ca2+, of
possible value for the investigation and treatment of Pb2+ intoxication.
 |
INTRODUCTION |
Lead remains as a pervasive toxin to which we are all exposed,
albeit at levels that vary substantially with geographical location,
occupation, and socioeconomic factors (1-3). To illustrate the
magnitude of this problem, on the order of 1 in 10 American children
currently possess blood lead levels above the toxic threshold of ~0.5
µM (reviewed in Ref. 4). The identification of mechanisms leading to lead toxicity is therefore of considerable interest and
actively investigated. Work of this type conducted at the cellular
level has been facilitated by the recent demonstration that entrapped
Indo-1 can be used to monitor Pb2+ transport into cells (5,
6), even though this fluorescent compound is responsive to changes in
the intracellular free Ca2+ concentration (7). Transport
studies utilizing Indo-1-loaded cells of several types have shown that
Pb2+ enters via plasma membrane Ca2+ channels
that are activated upon depletion of internal Ca2+ stores
(5, 6), as is also true for other toxic cations (8, 9).
The investigation of lead toxicity at a cellular level would benefit
from the availability of ionophores that transport Pb2+
selectively in comparison with other cations; however, to date, no
compound with this property has been identified. This situation may
reflect the use of cells and subcellular preparations in early studies
on the selectivity of ionophore-mediated transport (10). Biological
systems are not stable to toxic cations such as Pb2+,
making it difficult to use them for such purposes. In addition, the
difficulty inherent in distinguishing ionophore-derived transport from
transport occurring via endogenous channels and carriers may also have
discouraged attempts to identify ionophores that are selective for
Pb2+.
Unlike biological systems, phospholipid vesicles are stable to a wide
range of cations and conditions and are free of endogenous transport
activities. We have demonstrated that these structures, when prepared
by freeze-thaw extrusion, are useful for investigating the transport
mechanisms (11-13) and specificities (14, 15) of divalent cation
ionophores such as A23187, 4-BrA23187, and ionomycin. In this report,
we extend this work to include Pb2+ transport. The results
indicate that ionomycin is substantially selective as an ionophore for
Pb2+ and that this property is displayed in both
phospholipid vesicles and cultured A20 B lymphoma cells. Accordingly,
ionomycin may be useful for manipulating levels of Pb2+
during studies of its toxic properties in other cell types and at
higher levels of biological organization.
 |
EXPERIMENTAL PROCEDURES |
Reagents--
Synthetic
1-palmitoyl-2-oleoyl-sn-glycerophosphatidylcholine
(POPC)1 was obtained from
Avanti Polar Lipids, Inc. Purity was confirmed by thin-layer
chromatography before use. Ionomycin, A23187, and 4-BrA23187 were
obtained from Sigma, Calbiochem, or Teflabs and were used without
further purification. Stock solutions in ethanol were standardized
spectrophotometrically using the following extinction coefficients:
ionomycin,
278 = 13,560; A23187,
278 = 21,040; and 4-BrA23187,
290 = 15,600. Quin-2
(K+ salt) from Sigma was purified by passage over Chelex
100 resin (100-200 mesh) in the Cs+ form as described
previously (11). The nitrate and chloride salts of divalent cations
were the ultrapure grade from Alfa Products. Stock solutions of these
were standardized by titration with a primary standard EDTA solution
(16) or by atomic absorption spectroscopy using certified solutions (Fisher).
Preparation of Phospholipid Vesicles--
Freeze-thaw-extruded
POPC vesicles loaded with Quin-2 were prepared as described previously
(17, 18). Briefly, 300 mg of POPC in chloroform was dried by rotation
under a nitrogen stream to produce a film on the wall of a 25 × 150-mm culture tube. Residual solvent was removed under high vacuum (4 h), and the film was subsequently hydrated in 6 ml of a solution
containing 5 mM purified Quin-2 (Cs+) and 10.0 mM Hepes adjusted to pH 7.00 with Chelex-treated CsOH (11).
The mixture was vortexed, and the resulting multilamellar vesicles were
frozen in a dry ice/acetone bath, thawed in lukewarm water, and
vortexed again. The freeze-thaw and vortexing procedures were repeated
two additional times, after which the vesicles were extruded three
times through two stacked 100-nm polycarbonate membrane filters. This
step was followed by six additional freeze-thaw cycles coupled with
additional extrusions. The resulting preparations were applied to
Sephadex G-50 minicolumns (19) to remove extravesicular Quin-2. These
columns were eluted by low speed centrifugation and had previously been
equilibrated with a solution containing 10 mM Hepes, pH
7.00. A single pass over such columns effectively removes the external
Quin-2 (11, 17, 18).
The nominal concentration of POPC in the final preparations was
determined by measurement of lipid phosphorus (20) and was near 80 mM. The average diameter of these vesicles is 71 nm as determined by freeze-fracture electron microscopy (17), and they
contain entrapped solutes at the following concentrations; Quin-2,
10.5 ± 0.8 mM; Hepes, 34 ± 8 mM (pH
7.4); and Cs+, 60 ± 5 mM. Specific
values for Quin-2 and Cs+ were determined for each
preparation by the methods described previously (11, 12). Briefly,
entrapped Quin-2 was determined by spectrophotometric titration with
standard CaCl2 following dispersion of the vesicles in
deoxycholate. Entrapped Cs+ was determined by atomic
absorption spectroscopy following replacement of the external medium
with one not containing Cs+ and dispersion of the vesicles
in 0.1 N HCl. When of interest, buffer entrapment was
determined from the other values by calculation using the
Henderson-Hasselbach equation, the buffer pKa, and
the internal pH. When buffer entrapment was to be determined, the
vesicles also contained the fluorescent pH indicator
2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) so that the
internal pH could be ascertained. The internal pH and solute
concentrations differ from those of the vesicle formation medium
because of a freeze-thaw-driven solute concentrating effect that
operates during preparation of the vesicles (17, 18).
Vesicles loaded with BAPTA plus Indo-1 were prepared and characterized
in an analogous way. For those preparations, the formation medium
contained 5 mM BAPTA (in place of Quin-2) and 100 µM Indo-1. Accordingly, the resulting vesicles contained
a relatively high level of BAPTA and a much lower level of Indo-1. The
efficiency of BAPTA entrapment was similar to that of Quin-2 and was
determined by titrating the intact vesicles with standard
Ca2+ in the presence of excess ionomycin. Fluorescence of
the Indo-1·Ca2+ complex was monitored at 400 nm
(excitation at 336 nm) using an SLM-AMINCO 8100 spectrofluorometer
operated in the analog mode. The end point can be taken to represent
the end point for the simultaneous reaction of Ca2+ with
BAPTA because the two compounds have essentially the same affinity for
Ca2+ (7, 21), as described further under "Results."
Knowledge of Indo-1 entrapment was not required during the present
investigation, and that parameter was not determined.
Cell Culture and Loading of Cells with Indo-1--
A20 B
lymphoma cells (ATCC TIB-208) were grown to a density of 1.5-2.5 × 106 cells/ml at 37 °C under an atmosphere of 95% air
and 5% CO2. RPMI 1640 medium was employed and was
supplemented with 25 mM Na+/Hepes, pH 7.4, 100 units/ml penicillin, 100 µM streptomycin, 2 mM L-glutamine, and 5% fetal bovine serum
albumin (22). For loading with Indo-1, the cells were incubated for 45 min at 37 °C in a medium containing 4 µM Indo-1/AM
plus 140 mM NaCl, 3 mM KCl, 1 mM
CaCl2, 1 mM MgCl2, 10 mM Na+/Hepes, pH 7.4, and 10 mM
L-glucose (23). 1.0 mM probenecid was also
present to inhibit the release of Indo-1 after loading (24). Following
this, the loaded cells were maintained at 25 °C with gentle shaking
and were used within 6 h.
Cation Buffers and Determination of
Transport--
Pb2+ and Ca2+ were usually
presented from a buffer system for transport into the vesicles or
cells. 15 mM citrate was employed to buffer the
concentration of cations, whereas 10 mM each Hepes and Mes
were present to buffer H+. Seventeen equilibria involving
citrate3
, H+, Pb2+, and
OH
were accounted for when calculating the free
Pb2+ concentration when this cation was present alone. Six
additional equilibria involving Ca2+ were also considered
when both Pb2+ and Ca2+ were present and the
free concentration of both cations was of interest. The respective
equilibrium constants were taken from literature sources (25, 26), and
when necessary, the Davies equation (27) was used to correct these to
an ionic strength of 100 mM. The species distribution
program COMICS (28) was used to solve the applicable sets of
simultaneous equations at experimental conditions of interest and to
allow the generation of standard curves. As examples of the latter,
Fig. 1A shows how free
Pb2+ and PbOH+ vary in this system as a
function of total Pb2+ when the medium pH is 7.0. Fig.
1B shows the pH dependence of this system.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
Characteristics of the lead/citrate buffer
system. A, shown are the calculated values of free
Pb2+ ( ) and PbOH+ ( ) at pH 7.00 as a function of
total Pb2+ in the system. The total citrate concentration and
ionic strength were taken to be 15 and 100 mM,
respectively. B, values like those shown in A
were calculated for several pH conditions and were used to form the
three-dimensional surfaces that are shown. The dark and
light surfaces correspond to free levels of Pb2+ and
PbOH+, respectively.
|
|
The transport of Pb2+ and other divalent cations into
Quin-2-loaded vesicles was determined by monitoring formation of the
Quin-2·cation complexes spectroscopically. Vesicles containing Quin-2
were present at a nominal POPC concentration of 1.0 mM in a
medium that also contained 50 mM CsCl and 10 mM
each Hepes and Mes. The medium pH ranged from 6.0 to 8.0 and was
adjusted with CsOH that had been passed over Chelex 100 columns to
remove contaminating divalent cations (11). To maintain internal pH at
the external value, valinomycin (0.5 µM) and carbonyl
cyanide m-chlorophenylhydrazone (5 µM) were
also present (12). Specific concentrations of ionophores and divalent
cation chlorides and pH values are given in the figure legends.
Reactions were started by the addition of the divalent cation ionophore
following an initial 2-3-min period that was allowed for the
equilibration of transmembrane pH.
The formation of Quin-2·cation complexes was followed continuously by
difference absorbance spectroscopy using an SLM-AMINCO DW2a
spectrophotometer operated in the dual wavelength mode. An Oriel 59800 band-pass filter was used between the cuvette and the beam
scambler-photomultipler assembly to prevent detection of the
fluorescent light emitted by Quin-2. The sample wavelength used for all
cations was 264 nm. The reference wavelengths were at an isosbestic
point in the Quin-2/Quin-2·cation complex difference spectrum of
interest. These wavelengths vary slightly from cation to cation, as
described previously (14). Data were collected on disc using Unkel
Scope software.
The vesicles loaded with BAPTA plus Indo-1 were used to monitor the
simultaneous transport of Pb2+ and Ca2+, as
further described under "Results." Pb2+ transport into
Indo-1-loaded A20 B lymphoma cells was monitored as described by Kerper
and Hinkle (5, 6), with modifications that are also described under
"Results."
Other Methods--
To determine initial transport rates, an
early portion of the progress curves was fit to Equation 1 using
standard nonlinear least-squares methods.
|
(Eq. 1)
|
In this expression, AT and
A0 are the observed and the initial absorbance
values, respectively; B is the initial rate in units of
absorbance/s; C is a correction factor for nonlinearity; and
t is time. The values presented are in units of micromolar external cation transported into the vesicles/s. B values
obtained from Equation 1 were converted to the latter unit by referring to a standard curve for the cation of interest that was generated by
titrating the vesicles in the presence of excess ionophore or after
they had been lysed with 0.33% (w/v) Cs+ deoxycholate (11,
14). This was with the exception of Pb2+, where apparent
multiple equilibria between the cation and Quin-2 required a slightly
modified approach (see "Results"). Transport selectivities are
expressed as S values defined by Equation 2.
|
(Eq. 2)
|
When determining S, an equal concentration of the
cation in question is substituted for Ca2+ with all other
conditions held constant (14). All data were obtained at
25.0 °C.
 |
RESULTS |
Use of Quin-2-loaded Vesicles to Investigate Ionophore-catalyzed
Pb2+ Transport--
The vesicle-based transport system
employed here is useful for determining selectivity and mechanisms of
ionophore-mediated cation transport (11-15), but there are two
features of importance that must be accounted for when applying the
system to citrate-buffered solutions of Pb2+
(PbOH+). The first is an apparent slow permeation of
Pb2+ in the absence of an ionophore, as illustrated in Fig.
2A. This is seen at much lower
free Pb2+ concentrations than with Ca2+
permeation, with the uncatalyzed movements of both cations showing a
complex dependence on concentration and pH (Fig. 2B). Under the conditions we utilized, the rate of uncatalyzed transport was
usually negligible, but was determined, and data were corrected accordingly when it exceeded 2-3% of the ionophore-dependent
rate.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
Uncatalyzed transport of Pb2+ and
Ca2+. A, POPC vesicles containing Quin-2 were
incubated in a medium containing 15 mM citrate
(Cs+) plus 10 mM each Hepes and Mes. The nominal
concentrations of POPC and Quin-2 were 1.0 mM and 20 µM, respectively, and the external pH was adjusted to
7.00 using purified CsOH. Pb(NO3)2 was added to
establish the calculated concentrations of free Pb2+
(PbOH+ not considered) that are indicated to the right of
individual traces. From top to bottom, the
corresponding total Pb(NO3)2 concentrations were as
follows: 8.00, 4.00, 2.00, 1.00, 0.500, 0.125, and 0.031 mM. The entry of Pb2+ (PbOH+) was then
monitored spectroscopically, as formation of the Quin-2·Pb2+
complex, and these data were calibrated as described under
"Experimental Procedures." The y axis units refer to
total lead from the external medium that had entered the vesicles and
been complexed by Quin-2 at the time indicated on the x
axis. B, data like those shown in A were
obtained at three pH values as follows: pH 6.00 ( ), pH 7.00 ( ),
and pH 8.00 ( ). Initial rates of Pb2+ accumulation were
obtained from the progress curves as described under "Experimental
Procedures" and are shown as a function of the free Pb2+
concentration in external medium. Also shown is the rate of uncatalyzed
Ca2+ entry as a function of free Ca2+ at pH 6.00 ( ),
pH 7.00 ( ), and pH 8.00 ( ). Conditions were the same as those
used for Pb2+, except the total levels were adjusted to give
the desired concentrations of free Ca2+.
|
|
The second feature relates to an apparent formation of multiple
complexes between Pb2+ and entrapped Quin-2 and to how this
impacts on the calibration procedure used to relate the Quin-2
difference absorbance measurements to Pb2+ transport. When
the vesicles were suspended in an unbuffered Pb2+ solution
and the total Pb2+ available for transport exceeded the
total Quin-2 trapped within the vesicles, a biphasic progress curve was
obtained upon the addition of a Pb2+ ionophore (Fig.
3A). During the first phase,
entrapped Quin-2 approached an apparent saturation; however, as time
proceeded, a second phase was observed that would indicate a partial
release of previously accumulated Pb2+ if it were taken at
face value (Fig. 3A). However, titrating vesicle-entrapped
Quin-2 with Pb2+ in the presence of excess ionophore also
produced a biphasic pattern, wherein the apparent degree of saturation
decreased as Pb2+ was added beyond the 1:1 equivalence
point (Fig. 3B). In addition, biphasic transport curves were
not seen when Quin-2 was present in excess of total Pb2+
(data not shown), and titration data were less multiphasic when the
vesicles had been lysed to dilute the internal concentration of Quin-2
that originally existed (Fig. 3B).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Multiple complexes between Pb2+
and Quin-2. A, Quin-2-loaded vesicles were incubated as
described in the legend to Fig. 2, except that 50 mM CsCl
was present instead of cesium citrate, and the pH was 6.65. An
unbuffered Pb2+ concentration of 100 µM was
established by adding that concentration of Pb(NO3)2.
Where indicated, Pb2+ transport was initiated by the addition
of ionomycin at 1.0 µM. B, shown is the
fractional change in Quin-2 difference absorption, at 342 versus 264 nm, during titration of the compound with
Pb2+ ( ). Quin-2 was contained in POPC vesicles, and an
excess of ionomycin was present to equilibrate added
Pb(NO3)2 with the internal indicator. , Quin-2 was
released by lysing the vesicles with deoxycholate, as described under
"Experimental Procedures," before titrating with
Pb(NO3)2. The solid line shows that the two
sets of data are coincident until the total concentration of
Pb2+ exceeds ~22 µM. Total Quin-2 was 27 µM, as determined by titrating with Ca2+
(11).
|
|
We interpret these data to indicate that more than one complex is
formed between Pb2+ and the indicator under conditions that
pertain in the lumen of intact vesicles. There was no indication of
multiple complexes when this system was employed to investigate
ionophore-catalyzed transport of Ca2+ and other divalent
cations, such that this factor was not considered in the previous
studies that established procedures for utilizing the vesicle system to
investigate ionophore-mediated transport (11-15, 17, 18). Here we have
avoided possible errors in the reported rate and selectivity values by
deriving these parameters from the initial portion of the progress
curves, where internal Quin-2 was present in excess of internal
Pb2+. There was no disagreement between the internal and
external calibration methods within this region (Fig. 3B),
indicating that the same complex is considered in both cases.
Selectivity and Mechanism of Transport--
Ionomycin transported
Pb2+ more efficiently than other divalent cations as shown
in Fig. 4A. This is in
contrast to A23187 (Fig. 4B) and 4-BrA23187 (data not
shown), where rates of Pb2+ transport were intermediate in
comparison with the others. Selectivity for Pb2+ compared
with Ca2+ is of particular interest because
Pb2+ enters cells via channels that normally transport
Ca2+ (5, 6, 29) and because competition between these
cations at intracellular sites is important in mechanisms of
Pb2+ toxicity (30, 31). Using Equation 2 and the data in
Fig. 4, it can be shown that SPb is 98 for
ionomycin and only 2.3 for A23187 under the conditions of this
figure.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Transport of Pb2+ and other
divalent cations by Ca2+ ionophores. POPC vesicles
loaded with Quin-2 were incubated in a medium containing 50 mM CsNO3 plus 10 mM each Hepes and Mes.
The nominal concentrations of POPC and Quin-2 were 1.0 mM
and 20 µM, respectively. The external pH was adjusted to
7.00 using purified CsOH, and valinomycin (0.5 µM) plus
carbonyl cyanide m-chlorophenylhydrdazone (5 µM) were present to maintain the internal pH at the
external value. Divalent cations were present at 20 µM in
all cases (nitrate in the case of Pb2+ and chlorides for all
others). Instrumentation and other conditions were as described under
"Experimental Procedures." Transport was initiated at 0 s by the
addition of 0.10 µM ionomycin (A) or A23187
(B). A 2-min preincubation preceded the initiation of
transport to allow the equilibration of internal and external pH
(12).
|
|
The rate of ionomycin-catalyzed Pb2+ transport is a
function of the ionophore (Fig. 5) and
the Pb2+ (Fig. 6)
concentrations, as expected for a mechanism where a discrete complex
between the cation and the ionophore underlies activity. When the
ionophore concentration was varied, a plot of log initial rate
versus log of the ionophore concentration was well
represented by a straight line of slope 1.0, as was also true for
Ca2+ transport (Fig. 5) (11). Varying the free
Pb2+ concentration produced a log versus log
plot that also had a slope near 1 within the lower portion of the range
examined, but a progressively smaller value as the free
Pb2+ concentration rose (Fig. 6). This nonlinear behavior
was less apparent with Ca2+ transport (Fig. 6), which
resulted in lower values of SPb being obtained
from Equation 2 as higher concentrations of the two cations were
compared. To avoid this circumstance and to obtain a more representative value of SPb, we calculated a
value based upon the x axis separation of the plots within
regions where (near) linear behaviors were observed. Within these
regions, both sets of data were separated by 2.65 log units, which
translates into an SPb value of ~450.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of ionophore concentration on the
initial rate of Pb2+ transport. A, experiments
were conducted as described under "Experimental Procedures" and in
the legend to Fig. 4, except that free Pb2+ was buffered at 1.0 µM using citrate (see legend to Fig. 2), and the
ionomycin concentration was varied as shown to the right of the
individual traces. B, shown is the log of the initial
Pb2+ ( ) or Ca2+ ( ) transport rate as a function
of log ionomycin concentration. The data for Ca2+ transport
were determined from experiments like those shown in A,
wherein 1.0 µM free Ca2+ replaced
Pb2+.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of Pb2+ concentration on
the initial rate of Pb2+ transport. A,
experiments are analogous to those shown in Fig. 5, except that the
ionomycin concentration was held constant at 0.10 µM, and
the free Pb2+ concentration was varied as shown to the right of
the individual traces. B, shown is the log of the initial
Pb2+ ( ) or Ca2+ ( ) transport rate as a function
of log concentration for that cation. The data for Ca2+
transport were obtained from experiments like those shown in
A, wherein the free Ca2+ concentration was varied
instead of free Pb2+.
|
|
Competitive Transport of Pb2+ Versus Ca2+
in Vesicles--
To determine if ionomycin retains high transport
selectivity for Pb2+ over Ca2+ when both
cations are present, we utilized vesicles loaded with BAPTA plus a
small amount of Indo-1, rather than Quin-2. Quin-2-loaded vesicles are
not suitable for investigating simultaneous transport because there is
no spectral distinction between the primary Pb2+ and
Ca2+ complexes that are formed with this indicator. The
same is true for the corresponding BAPTA complexes; however, the
Pb2+ and Ca2+ complexes of Indo-1 can be
distinguished by their fluorescence properties as reported by Kerper
and Hinkle (5, 6).
Fig. 7 illustrates, in part, how the
differences they described can be exploited to allow initial rates to
be obtained for the two cations individually when both are present.
Titration of vesicles containing BAPTA plus Indo-1 with
Pb2+ in the presence of high ionomycin allowed the external
cation to equilibrate with the internal chelators, as shown earlier for Quin-2-loaded vesicles titrated with Ca2+ (11). As such a
titration proceeded, Pb2+ association with Indo-1 quenched
its fluorescence emission at 452 nm (Em452), while having a
much smaller effect on Em400 (Fig. 7A). The
former wavelength is an isosbestic point between the emission spectra
of free Indo-1 and its Ca2+ complex (5, 6), whereas the
latter is a maximum in the spectrum of the Ca2+ complex (7)
and is little affected upon the binding of Pb2+ (6).
Accordingly, the entry of Pb2+ during a continuous
transport experiment should progressively decrease Em452,
without affecting Em400, and this was observed (Fig.
7B). Likewise, titrating the vesicles with Ca2+
increased Em400 and had a much smaller effect on
Em452 (Fig. 7C), whereas the same features were
again apparent during entry of Ca2+ by continuous transport
(Fig. 7D).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 7.
Indo-1 fluorescence distinguishes between
Pb2+ and Ca2+ transport. A, POPC
vesicles loaded with BAPTA plus Indo-1 were incubated in a medium
containing 50 mM CsNO3 plus 10 mM each
Hepes and Mes. The nominal concentrations of POPC and BAPTA were 1.0 mM and 20 µM, respectively, and Indo-1 was
present at <1 µM. The external pH was adjusted to 7.00 using purified CsOH. Valinomycin (0.5 µM) plus carbonyl
cyanide m-chlorophenylhydrazone (5 µM) were
present to maintain the internal pH at the external value, and 1.0 µM ionomycin was present to rapidly equilibrate external
Pb2+ with the internal chelators. and , change in Indo-1
fluorescence at 400 and 452 nm, respectively (excitation at 336 nm),
during titration of the system with Pb(NO3)2.
B, same as A, except that 15 mM
cesium citrate replaced CsNO3, and 125 µM
Pb(NO3)2 was present to establish a free Pb2+
concentration of 81 nM. Transport was initiated by the
addition of ionomycin, where indicated, and fluorescence at 400 and 452 nm was monitored by rapid scanning. C, same as A,
except that the vesicles were initially titrated with Ca2+
rather than Pb2+, until the total Ca2+ added reached 41 µM. Thereafter, the titration was continued by adding
Pb2+. Above 41 µM, the x axis units
refer to the sum of Ca2+ and Pb2+ that had been added.
D, same as B, except that 3.00 mM
Ca(NO3)2 replaced Pb(NO3)2 to establish
a free Ca2+ concentration of 89 µM.
|
|
Thus, the accumulation of Pb2+ or Ca2+ gives
rise to distinct fluorescence signals from the entrapped Indo-1.
However, as the accumulation of either cation proceeds, most of the
internal quantity is associated with BAPTA, whereas Indo-1 equilibrates
with the fraction that is free. To relate the wavelength-specific
fluorescence changes to rates of transport, the relationships between
fractional Indo-1 and BAPTA saturation must be taken into account. The
stability constants of the BAPTA and Indo-1 complexes with
Ca2+are similar at 6.03 × 106 and
4.36 × 106, respectively (7, 21). In the case of
Pb2+, the corresponding values are 1.99 × 1011 (21) and 2.88 × 1010 (5). Given the
inherent uncertainties, the Ca2+ values could probably be
considered equivalent; however, this is not true in the case of
Pb2+, which is bound 6.9-fold more tightly by BAPTA than by
Indo-1. Ignoring this discrepancy would cause the Pb2+
transport rate to be underestimated significantly.
To correct for the discrepancy, we used the maximum and minimum
Em452 values observed when no Pb2+ and
saturating Pb2+ were present, respectively, to calculate
the Indo-1/Indo-1·Pb2+ complex ratio at each point in the
progress curves. These values were converted to free Pb2+
concentrations using the stability constant of the
Indo-1·Pb2+ complex, and thereafter, the
BAPTA/BAPTA·Pb2+ ratio could be calculated using the
stability constant for the complex formed between that ligand and
Pb2+. From the resulting values and the amount of BAPTA
entrapped, Pb2+ accumulated as a function of time could be
calculated (free Pb2+ and Pb2+ associated with
Indo-1 can be ignored because they are small compared with the
BAPTA-associated Pb2+). An analogous procedure was applied
to the Ca2+ accumulation data obtained as
Em400.
Fig. 8 shows the results of these
procedures when applied to determine SPb. When
the medium free Ca2+/free Pb2+ ratio was
~900, the initial rate of Pb2+ transport was 3.5-fold
greater than the rate of Ca2+ transport. Thus, under
conditions of simultaneous transport, SPb is
~3200 in comparison with Ca2+. The release of
Ca2+ that was seen as Pb2+ accumulation
proceeded represents the displacement of Ca2+ from Indo-1
(and BAPTA) by the more tightly bound Pb2+ (Fig. 8). This
was also seen when vesicles were first titrated with Ca2+
and then with Pb2+ (Fig. 7C).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 8.
Simultaneous transport of Pb2+
and Ca2+. Vesicles loaded with BAPTA plus 100 µM Indo-1 (rather than Quin-2) were employed. The
external medium conditions were as described in the legend to Fig. 7,
except that 125 µM Pb(NO3)2 and 3.00 mM Ca(NO3)2 were both present to establish
citrate-buffered free Pb2+ and Ca2+ concentrations of
81 nM and 89 µM, respectively. 1.0 µM ionomycin was added at 0 s to intiate the transport of
Pb2+ and Ca2+. Indo-1 was excited at 336 nm, with
emission monitored at 400 nm (Ca2+ transport) and 452 nm
(Pb2+ transport) by rapid scanning, and the original data were
corrected for the affinity differences of BAPTA and Quin-2 for
Pb2+ and Ca2+ as described under "Results." In the
inset, the free Ca2+ concentration was increased to
1.0 mM, and the free Pb2+ concentration was varied
as shown. Progress curves like those shown in the main panel were
obtained, and initial rate values were determined.
|
|
Fig. 8 (inset) shows the dependence of Pb2+ and
Ca2+ transport on Pb2+ concentration when the
external free Ca2+ concentration is 1 mM.
Approximately 1 µM free Pb2+ decreased the
Ca2+ transport rate by 50%, whereas the rate for
Pb2+ transport approached a maximum as the free
Pb2+ concentration approached 10 µM. The
methods we employed to correct the data for differing stabilities of
the Indo-1 and BAPTA complexes with Pb2+ and
Ca2+ do not account for all factors of possible
interest2; however, it is
clear that a very high selectivity for Pb2+ over
Ca2+ is manifested by ionomycin when both cations are present.
Pb2+ Transport in Cells--
Ionomycin-catalyzed
Pb2+ transport into A20 B lymphoma cells is demonstrated in
Fig. 9. Fig. 9A was obtained
using cells that were maintained in growth medium during loading with
Indo-1.
N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), the membrane-permeant chelator of heavy metal cations (32),
increased Em452 when added to these cells, indicating the
presence of contaminates (Fig. 9A). This was not seen when the cells were in the defined medium during loading (Fig. 9B
and data not shown) so that condition was adopted. The addition of the
impermeant chelator DTPA (Fig. 9B) or 1 µM
free Pb2+ (Fig. 9C) was also without an
immediate effect on Em452, demonstrating the absence of
Indo-1 and its Ca2+ complex in the external volume. Thus,
these cells, when loaded with Indo-1, are an appropriate system for the
investigation of Pb2+ transport.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 9.
Ionophore mediated Pb2+ transport
in A20 lymphoma cells. Cells were grown and loaded with Indo-1 as
described under "Experimental Procedures." They were incubated at
25 °C and 1 × 106 cells/ml in a medium containing 140 mM NaCl, 3 mM KCl, 1 mM each
CaCl2 and MgCl2, 10 mM Na+/Hepes,
pH 7.4, 10 mM glucose, and 1.0 mM probenecid.
For all traces, a downward deflection indicates Pb2+
accumulation. In A and B,
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine
(TPEN) and DTPA were added at 100 µM where
indicated. In A, the cells were incubated in growth medium
during loading with Indo-1, whereas in B and all other
experiments, the incubation medium was employed. In C and
D, 15 mM citrate and 2.0 mM
PbCl2 were present to establish buffered concentrations of free
Pb2+ and Ca2+ at 1.1 and 25 µM,
respectively. In C, PbCl2 was added where indicated.
In other cases, it was present from the beginning. In D, 0.5 µM ionomycin was added where indicated. The data in
E were obtained from experiments similar to the one
illustrated by D, except the level of ionomycin or
Pb2+ was varied. , ionomycin was varied, and free
Pb2+ was present at 0.38 µM; , free
Pb2+ was varied, and ionomycin was present at 0.5 µM. Cell viability was checked at the end of individual
experiments and had not decreased below the initial range of
90-95%.
|
|
As with other cell types, Pb2+ entered A20 lymphoma cells
slowly when it was present at a free concentration of 1 µM (Fig. 9C). The rate was markedly
accelerated by 0.5 µM ionomycin (Fig. 9D), demonstrating that the compound is active as a Pb2+
ionophore in this biological system. As with vesicles, the rate of
transport is a function of the Pb2+ and ionomycin
concentrations over a broad range of either parameter. This is shown by
Fig. 9E, which summarizes concentration dependence data
covering 2 orders of magnitude in both cases.
Fig. 10 demonstrates that
ionomycin-mediated Pb2+ transport in cells is reversible.
To obtain these data, the Pb2+/citrate buffer system was
replaced by 20 µM Pb(NO3)2 to
yield a free Pb2+ concentration in that range. As with
other cells, Pb2+ rapidly entered A20 B lymphoma cells
through endogenous activities when present at this higher concentration
(Fig. 10, data obtained as Em452). The entry was
accelerated by ionomycin addition and reversed by the subsequent
addition of excess EDTA. Like DTPA, EDTA is membrane-impermeant and
binds Pb2+ with high affinity. Thus, the recovery of
Em452 following the addition of EDTA indicates that
internal Pb2+ was released from Indo-1, transported out of
the cells, and chelated in the external volume. Also shown are the
parallel changes in Em400, reflecting, in part, the
accompanying changes in free Ca2+. Em400
decreased as Pb2+ entered the cells initially, consistent
with a displacement of endogenous Ca2+ from Indo-1 by the
more tightly bound Pb2+. Conversely, Em400 rose
to a high level upon EDTA addition and Pb2+ depletion,
indicating that the cytoplasmic Ca2+ concentration is
increased progressively as Pb2+ is removed. This rising
Ca2+ level presumably reflects an ionomycin-mediated entry
of Ca2+ from the external volume and possibly a release of
Ca2+ from internal stores into the cytoplasm.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 10.
Release of Pb2+ from A20
lymphoma cells. Indo-1-loaded cells were incubated as described in
the legend to Fig. 9. Excitation was at 336 nm for both traces, whereas
emission was monitored by rapid scanning between 452 nm (solid
line) and 400 nm (dotted line).
Pb(NO3)2 (20 µM), ionomycin
(Iono; 0.10 µM), and EDTA (200 µM) were added as indicated.
|
|
 |
DISCUSSION |
Early studies utilizing solvent extraction systems, sarcoplasmic
reticulum vesicles, and mitochondrial preparations established that
ionomycin is a Ca2+ ionophore (33-35), and it has long
been utilized in that regard. More recently, it has become clear that
this compound binds and transports a wide range of cations, including
alkaline earth and first transition series divalent cations and
lanthanide series trivalent cations (14, 15, 36). Among all the cations
considered to date, ionomycin is the most active by far as an ionophore
for Pb2+. Accordingly, it seems appropriate to describe
this compound as a Pb2+ ionophore that has a limited
activity for the transport of other polyvalent cations such as
Ca2+. Pb2+ transport by ionomycin is a
first-order function of ionophore concentration, as indicated by the
linear character and slope value of 1.0 that are seen in plots of log
initial rate versus log ionomycin concentration (Fig. 5).
The same is true with respect to Pb2+ concentration within
the lower portion of the range examined (Fig. 6). Where these
relationships hold, the rate of Pb2+ transport can be
described by Equation 3, in which ktrans is a
second-order rate constant that is valid at the pH and temperature employed.
|
(Eq. 3)
|
The versatility of the vesicle transport system with respect to
cations that can be considered and the range of conditions that are
accessible makes it possible to express the efficiency and selectivity
of ionophore-catalyzed transport in terms of rate constants. These
values are usually not accessible when traditional methods are employed
to characterize ionophores. From the present data,
ktrans values for Pb2+ and
Ca2+ transport are 1.2 × 106 and 2.7 × 103 M
1 s
1, respectively.
Within the concentration regions where Equation 3 is applicable, the
stoichiometry of the transporting species must be 1:1, ionophore to
cation, based upon the first-order kinetic characteristics (slope
values of 1.0 in the log versus log plots). Ionomycin is a
monocarboxylic acid that contains an enolized
-diketone moiety (37)
and can therefore ionize twice to form 1:1 charge neutral complexes
with divalent cations (36). Thus, it is possible that Pb2+
is transported as the neutral species IPb, formed according to Equation 4, wherein H2I is the fully protonated form.
|
(Eq. 4)
|
However, monoprotonated complexes between ionomycin and several
divalent cations have been identified (36), and charge neutral
complexes of 1:1 stoichiometry are formed between ionomycin and
trivalent lanthanide cations, apparently by the inclusion of an
OH
(15). Since Pb2+ and Pb2+
complexes are prone to hydrolyze (38-40), it is then possible that the
weakly acidic enolized
-diketone moiety remains protonated in the
transporting species and that this species contains OH
.
Thus, a mixed complex of stoichiometry H·IPb·OH might also be responsible for transporting Pb2+, wholly or in part. An
unambiguous identification of the transporting species must await
determination of the mode of transport (electroneutral, electrogenic,
or mixed) and investigation of the complexation equilibria between this
ionophore and Pb2+.
Explanations for the progressive curvature in plots of log rate
versus log Pb2+ concentration that is evident at
higher values of free Pb2+ (Fig. 6) and the increase in
SPb compared with Ca2+ that is seen
when both cations are present (Fig. 8) also await investigation of the
complexation equilibria between Pb2+ and ionomycin.
Regarding the former, we suspect that curvature reflects an approach to
saturation of the ionophore with Pb2+ as the free
concentration of the cation rises. However, it is also possible that it
reflects the reaction of a 1:1 transporting species with a second
Pb2+ ion to form species such as IPb2 (Equation 5, charge and hydroxylation status not specified) that are unable to
cross membranes.
|
(Eq. 5)
|
If the higher order species were less stable than the transporting
species, the result would be less ionophore contributing to transport
as the free Pb2+ concentration increased, producing the
type of curvature that is observed (Fig. 6).
Regarding the high value of SPb that is seen
when Pb2+ and Ca2+ are present, it seems
possible that both complexation equilibria and differing transmembrane
diffusion constants contribute to the explanation. For example, if
Pb2+ were bound more tightly than Ca2+, but
formed a transporting complex that crossed the membrane relatively
slowly compared with the complex transporting Ca2+, the
result could be an increase in the apparent selectivity when both
cations were present, which is what we observed (Fig. 8).
Legare et al. (29) reported that ionomycin transports
Pb2+ into primary cultures of rat astroglia cells, and our
results with A20 B lymphoma cells extend their findings. We cannot
compare the activity values in vesicles and cells quantitatively
because the relationship between free and total Pb2+ in the
cells is unknown. In addition, the total aqueous/lipid phase volume
ratios are not similar at the vesicle and cell concentrations we
employed. Accordingly, and for other reasons, the fraction of ionophore
that is partitioned to the lipid phase and engaged in transport is
probably different in the two systems (much larger in the case of
vesicles). Nevertheless, it is clear that ionomycin retains a high
activity as a Pb2+ ionophore in cells. This is seen
qualitatively in Fig. 9D, where 0.5 µM
ionomycin efficiently loaded the cells with Pb2+ when the
external free Pb2+ concentration was 1 µM.
The former value is typical of ionomycin concentrations used to load
cells with Ca2+, whereas the cation concentration employed
in that case is normally much higher (millimolar). The Pb2+
transport activity of ionomycin will, presumably, be a useful addition
to the approaches used for investigating the toxic activities of
Pb2+ at a cellular level.
A final point relates to the reversibility of ionomycin-mediated
Pb2+ transport that is demonstrated in Fig. 10. It is
interesting to note that the ionophore-mediated release of
Pb2+ appears to be more rapid than the initial
accumulation. This same difference was seen earlier for
Ca2+ transport using the vesicle system, in which
Ca2+ release occurs 20 times faster than uptake (11). The
differing rates are thought to reflect the large difference in volume
of the aqueous phase compartments accessible from alternate sides of
the membrane and the effect of this on ionophore levels at the two
interfaces where transporting species are formed (11). It seems
possible that efficient release of Pb2+ from cells when
ionomycin is present will extend to higher levels of biological
organization and reach a practical application as follows. Lead
intoxication is treated by the administration of chelating agents that
complex Pb2+ in blood and are subsequently secreted by the
kidney (41, 42). The agents must be given repeatedly over a lengthy
time course. There are reports that multiple hydrophilic chelators
administered simultaneously remove accumulated lead more effectively
than single compounds (43) and that a degree of hydrophobicity improves single compound effectiveness (44-46). Low levels of a lead ionophore administered together with a hydrophilic chelator might capture the
multiple chelator advantage and the hydrophobicity advantage simultaneously. The result could be an improved treatment for lead
intoxication, both in terms of the completeness of removal and a
shorting of the treatment period required.
 |
ACKNOWLEDGEMENTS |
We thank Dr. K. Mark Coggeshall and
co-workers, who initially provided A20 B lymphoma cells and helped to
establish the culture of these cells in our laboratory.
 |
FOOTNOTES |
*
This work was supported by United States Public Health
Service Grant HL49181 from NHLBI, National Institutes of Health, and by
the Wallace Research Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of Medical
Biochemistry, Ohio State University, 1645 Neil Ave., 310A Hamilton Hall, Columbus, OH 43210-1218. Tel.: 614-292-8774; Fax: 614-292-4118.
2
The amount of Ca2+ transported is
progressively underestimated in Fig. 8 because we have not corrected
the progress curve for the reduction in Indo-1 available to associate
with Ca2+ as Pb2+ accumulation proceeds. The
available Indo-1 is progressively decreased because Pb2+ is
bound much more tightly than Ca2+, which essentially
removes the Pb2+ associated indicator from the equilibrium
involving Ca2+. This factor was not considered because our
interpretations are based upon initial rates, which are not affected by
this feature of the system.
 |
ABBREVIATIONS |
The abbreviations used are:
POPC, 1-palmitoyl-2-oleoyl-sn-glycerophosphatidylcholine;
BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid;
Mes, 2-(N-morpholino)ethanesulfonic acid;
DTPA, diethylenetriaminepentaacetic acid.
 |
REFERENCES |
| 1.
|
Lanphear, B. P.,
Burgoon, D. A.,
Rust, S. W.,
Eberley, S.,
and Galke, W.
(1998)
Environ. Res.
76,
120-130[Medline]
[Order article via Infotrieve]
|
| 2.
|
Mielke, H. W.,
and Reagan, P. L.
(1998)
Environ. Health Perspect.
106,
217-229
|
| 3.
|
Kristal-Boneh, E.,
Froom, P.,
Yerushalmi, N.,
Harari, G.,
and Ribak, R.
(1998)
Am. J. Epidemiol.
147,
458-463[Abstract/Free Full Text]
|
| 4.
|
Gutgesell, M. E.
(1996)
VA Med. Q.
123,
190-191[Medline]
[Order article via Infotrieve]
|
| 5.
|
Kerper, L. E.,
and Hinkle, P. M.
(1997)
J. Biol. Chem.
272,
8346-8352[Abstract/Free Full Text]
|
| 6.
|
Kerper, L. E.,
and Hinkle, P. M.
(1997)
Toxicol. Appl. Pharmcol.
146,
127-133[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Cobbold, P. H.,
and Rink, T. J.
(1987)
Biochem. J.
248,
313-328[Medline]
[Order article via Infotrieve]
|
| 8.
|
Hinkle, P. M.,
Shanshala, E. D., II,
and Nelson, E. J.
(1992)
J. Biol. Chem.
267,
25553-25559[Abstract/Free Full Text]
|
| 9.
|
Sensi, S. L.,
Canzoniero, L. M. T., Yu, S. P.,
Ying, H. S.,
Koh, J. Y.,
Kerchner, G. A.,
and Choi, D. W.
(1997)
J. Neurosci.
17,
9554-9564[Abstract/Free Full Text]
|
| 10.
|
Reed, P. W.
(1982)
in
Polyether Antibiotics: Naturally Occurring Acid Ionophores
(Westley, J. W., ed)
, Marcel Dekker, Inc., New York
|
| 11.
|
Erdahl, W. L.,
Chapman, C. J.,
Taylor, R. W.,
and Pfeiffer, D. R.
(1994)
Biophys. J.
66,
1678-1693[Abstract/Free Full Text]
|
| 12.
|
Erdahl, W. L.,
Chapman, C. J.,
Taylor, R. W.,
and Pfeiffer, D. R.
(1995)
Biophys. J.
69,
2350-2363[Abstract/Free Full Text]
|
| 13.
|
Thomas, T. P.,
Wang, E.,
Pfeiffer, D. R.,
and Taylor, R. W.
(1997)
Arch. Biochem. Biophys.
342,
351-361[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Erdahl, W. L.,
Chapman, C. J.,
Wang, E.,
Taylor, R. W.,
and Pfeiffer, D. R.
(1996)
Biochemistry
35,
13817-13825[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Wang, E.,
Taylor, R. W.,
and Pfeiffer, D. R.
(1998)
Biophys. J.
75,
1244-1254[Abstract/Free Full Text]
|
| 16.
|
Vogel, A. I.
(1961)
Quantitative Inorganic Analysis
, 3rd Ed.
, pp. 415-446, John Wiley & Sons, Inc., New York
|
| 17.
|
Chapman, C. J.,
Erdahl, W. L.,
Taylor, R. W.,
and Pfeiffer, D. R.
(1990)
Chem. Phys. Lipids
55,
73-83[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Chapman, C. J.,
Erdahl, W. L.,
Taylor, R. W.,
and Pfeiffer, D. R.
(1991)
Chem. Phys. Lipids
60,
201-208[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Fry, D. W.,
White, J. C.,
and Goldman, D.
(1978)
Anal. Biochem.
90,
809-815[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Bartlett, G. R.
(1959)
J. Biol. Chem.
234,
466-468[Free Full Text]
|
| 21.
|
Yuchi, A.,
Tanaka, A.,
Hirai, M.,
Yasui, T.,
Wada, H.,
and Nakagawa, G.
(1993)
Bull. Chem. Soc. Jpn.
66,
3377-3381[CrossRef]
|
| 22.
|
Diegel, M. L.,
Rankin, B. M.,
Bolen, J. B.,
Dubois, P. M.,
and Kiener, P. A.
(1994)
J. Biol. Chem.
269,
11409-11416[Abstract/Free Full Text]
|
| 23.
|
Marriott, I.,
and Mason, M. J.
(1996)
J. Biol. Chem.
271,
26732-26738[Abstract/Free Full Text]
|
| 24.
|
Di Virgilio, F.,
Fasolato, C.,
and Steinberg, T. H.
(1988)
Biochem. J.
256,
959-963[Medline]
[Order article via Infotrieve]
|
| 25.
|
Smith, R. M.,
and Martell, A. E.
(1976)
Critical Stability Constants
, Plenum Press, New York
|
| 26.
|
Martell, A. E.,
and Smith, R. M.
(1977)
Critical Stability Constants
, Plenum Press, New York
|
| 27.
|
Davies, C. W.
(1962)
Ion Association
, Butterworth-Heinemann Ltd., London
|
| 28.
|
Perrin, D. D.,
and Sayce, I. G.
(1967)
Talanta
14,
833-842[CrossRef]
|
| 29.
|
Legare, M. E.,
Barhoumi, R.,
Hebert, G. R.,
Burghardt, R. C.,
and Tiffany-Castiglioni, E.
(1998)
Toxicol. Sci.
46,
90-100[Abstract/Free Full Text]
|
| 30.
|
Quinn, M. R.,
and Harris, C. L.
(1995)
Neurosci. Lett.
196,
65-68[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Schanne, F. A. X.,
Long, G. J.,
and Rosen, J. F.
(1997)
Biochim. Biophys. Acta
1360,
247-254[Medline]
[Order article via Infotrieve]
|
| 32.
|
Arslan, P.,
Di Virgilio, F.,
Beltrame, M.,
Tsien, R. Y.,
and Pozzan, T.
(1985)
J. Biol. Chem.
260,
2719-2727[Abstract/Free Full Text]
|
| 33.
|
Liu, C.-M.,
and Hermann, T. E.
(1978)
J. Biol. Chem.
253,
5892-5894[Abstract/Free Full Text]
|
| 34.
|
Beeler, T. J.,
Jona, I.,
and Martonosi, A.
(1979)
J. Biol. Chem.
254,
6229-6231[Abstract/Free Full Text]
|
| 35.
|
Kaufman, R. F.,
Taylor, R. W.,
and Pfeiffer, D. R.
(1980)
J. Biol. Chem.
255,
2735-2739[Abstract/Free Full Text]
|
| 36.
|
Stiles, M. K.,
Craig, M. E.,
Gunnell, S. L. N.,
Pfeiffer, D. R.,
and Taylor, R. W.
(1991)
J. Biol. Chem.
266,
8336-8342[Abstract/Free Full Text]
|
| 37.
|
Toepilitz, B. K.,
Cohen, A. I.,
Funke, P. T.,
Parker, W. L.,
and Gougoutas, T. Z.
(1979)
J. Am. Chem. Soc.
101,
3344-3353[CrossRef]
|
| 38.
|
Baes, C. F. J.,
and Mesner, R. F.
(1976)
The Hydrolysis of Cations
, John Wiley & Sons, Inc., New York
|
| 39.
| Sylva, R. A., and Brown, P. L. (1980) J. Chem.
Soc. Dalton Trans. 1577-1581
|
| 40.
|
Springer, M. E.,
and Taylor, R. W.
(1988)
Inorg. Chem.
27,
165-168[CrossRef]
|
| 41.
|
Goyer, R. A.,
Cherian, M. G.,
Jones, M. M.,
and Reigart, J. R.
(1995)
Environ. Health Perspect.
123,
1-9
|
| 42.
|
Lifshitz, M.,
Hashkanazi, R.,
and Phillip, M.
(1997)
Ann. Med.
29,
83-85[Medline]
[Order article via Infotrieve]
|
| 43.
|
Domingo, J. L.
(1995)
Reprod. Toxicol.
9,
105-113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Lee, B. K.,
Schwartz, B. S.,
Stewart, W.,
and Ahn, K. D.
(1995)
Occup. Environ. Med.
52,
13-19[Abstract]
|
| 45.
|
Besunder, J. B.,
Super, D. M.,
and Anderson, R. L.
(1997)
J. Pediatr.
130,
966-971[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Jones, M. M.,
Singh, P. K.,
Kostial, K.,
Blanusa, M.,
Piasek, M.,
and Restek-Samarozija, N.
(1997)
Pharmacol. Toxicol.
80,
182-186[Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg